Results 271 to 280 of about 3,155,046 (320)
Some of the next articles are maybe not open access.

Immunologic Nonresponsiveness to Tumors

Critical Reviews™ in Oncogenesis, 1998
Over the past several years it has become clear that malignant cells express a variety of tumor associated antigens, and T cells reactive to these antigens have been identified. However, the T cells are not effective in rejecting tumors. In general, T cells that are not tolerized within the thymus have the potential to be rendered tolerant by one of ...
Martine Extermann   +2 more
openaire   +3 more sources

Immunology of Cardiac Tumors

The Thoracic and Cardiovascular Surgeon, 1990
Whereas abundant literature is available on mechanisms imposed by neoplastic diseases on the immune system, only few details are known about immunological parameters of autoreactive mechanisms directed against the heart. This report will focus on cardiac autoreactivity in patients with endomyocardial types of cardiac tumors (e.g.
openaire   +3 more sources

Tumor immunology and immunotherapy

The Laryngoscope, 1977
AbstractTumor cells contain a variety of antigens, including tumor associated antigens. The tumor associated antigens can be clinically useful as marker's for detection of cancer and some may also mediate host resistance against tumor growth. Much emphasis has been placed on the detection of circulating tumor associated markers, with radioimmunoassays ...
openaire   +3 more sources

Current Issues in Tumor Immunology

Current Bioinformatics, 2010
The goal of tumor immunology is to understand the interactions between tumor cells and immune system, and ultimately to devise immune basedapproaches to fight cancer. We discuss here recent advances in tumor immunology and in the interaction between immunology and informatics that provide new perspectives for the development of cancer ther- apy. Cancer
ASTOLFI, ANNALISA   +3 more
openaire   +5 more sources

Logistics of tumor immunology

Klinische Wochenschrift, 1982
This article deals with the experimental problems of tumor immunology. It stresses that animal tumors should in their pathogenesis closely reflect the pathogenesis of human cancer because otherwise they may be useless and cloud the issues instead of making useful contributions.
openaire   +3 more sources

Horizons in Tumor Immunology

Archives of Surgery, 1974
Dr. Wilson: Although we really have to thank the Gordon Conference for attracting two of our three speakers to Boston this morning, we are pleased to have them under any circumstances because we are excited about this seminar. I have entitled the seminar "Horizons in Tumor Immunology" because I hope the speakers will be presenting a synthesis of new ...
Steven A. Rosenberg   +4 more
openaire   +3 more sources

Tumor Immunology and Interferon

Southern Medical Journal, 1978
Host defense mechanisms against cancer depend on an intact cellular immunity system. Immunosurveillance depends on thymus lymphocytes which, when sensitized, form lymphokines. One of the important lymphokines produced by T-lymphocytes is called interferon, well known for its antiviral effects.
openaire   +3 more sources

Complement And Tumor Immunology

1971
Publisher Summary This chapter provides an overview of the theoretical considerations and practical applications of complement research to tumor immunology in each of five projects—namely, (1) the immunological cell receptors, (2) immune adherence, (3) C1 fixation and transfer test, (4) complement fixation test, and (5) immune cytotoxicity test ...
openaire   +3 more sources

Predictive Models in Tumor Immunology

2008
The role of the immune system in tumor surveillance is clearly established, and tumor immunologists are actively working to devise preventive and therapeutical vaccines against cancer; however, the growth of biological knowledge is still too slow to win the war against cancer as soon as possible.
LOLLINI, PIER LUIGI   +3 more
openaire   +4 more sources

Immunology in Tumor and Transplant

2020
The immune response is started any time the immune system encounters an allo-antigen (bacteria, tumor or heterologous graft, etc.). The immune response consists in three steps: recognition of the alloantigen, activation of the lymphocyte T, destruction of the target by cellular or humoral ways; and involve several actors: Antigen Presenting Cell (APC),
Romain Boissier   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy